Turn Your $1,000 Into Over 2 Million Dollars With Their Help  at
http://www.stocksmastermind.com

Turn Your $1,000 Into Over 2 Million Dollars With Their Help  at
http://www.stocksmastermind.com

Dear Friends:

SNBP is our New Pick www.sinobiopharma.com

SINO BIOPHARMA SNBP a Fully integrated specality biopharmaceutical
company with 30,000 sq.meter Certified Production Facilities in China.

Estimated Chinese Health Care Market Demand of $600 Billion by 2015.We
all are aware China’s Current population is 1.4 Billion.

SNBP traded as high as $2.0 in the PAST, we can shoot for a gain of
8400%

Leadership of CEO Dr. Lequn Lee Huang a former manager of the Bayer
Co., one of the world's largest pharmaceutical companies and CFO Mr.
Dong Ying formerly of JP Morgan Chase.

SNBP Anesthetics Projected sale of 1.5 million units and 500,000
tablets for cardiovascular diseases in 2009.

Key Drives:
Outstanding financial results; more than 2000% growth in 3 years.
4 key marketed products; multiple products in pipeline.
R&D Partnership with Cornell University and 3 Top Universities in
China.
Established Nation wide Sales and Marketing Network in China.
Aging Population & Increasing Life Style diseases.
Improving Health Insurance Programs and Coverage.

PLAN FOR FUTURE: Sinobiopharma has a clearly defined strategy to drive
short, middle and long term growth.  All drug development will
leverage the Company's patented technology for fast, low-cost drug
synthesis and new technology for formulation.

Check out Complete Presentation only at www.stockexploder.com
Please do your own due diligence on SNBP
All The Best

Exploder

www.stockexploder.com
 *Never invest in a stock mentioned by stockexploder.com unless you
can afford to lose your entire investment. For full disclaimer
http://www.stockexploder.com/disclaimer.html

Turn Your $1,000 Into Over 2 Million Dollars With Their Help  at
http://www.stocksmastermind.com

OH YES
KBLB IS THE SIMBOL
HAVE A GREEN DAY

我创建了一个专门用于讨论美股基本面的QQ群:89851125。希望广大热衷于价值投资的朋友加入进来，共同探讨，共同提高。这是一个非公开的群，只
接收投资理念相似的人。如果你以技术分析为自己的投资依据，请寻找其它适合你的群组，如果你是听消息，凭感觉，看不懂财务报表的人，请过几年再来。希望
加入的朋友，请将你有一定了解的公司，写份分析报告（可长可短，但不要太短而没内容），发送到chen862*gmail.com,写上你的QQ号，同
时加入这个QQ群，我会据此通过你的申请验证，同时，你的分析报告也会贴在这个群的空间中，供其它朋友查阅。相信每个人基于自己所在行业及对周围信息的
了解，会对相关公司有更深的理解。

Item 4.  Ownership

The information in items 1 and 5 through 11 on the cover page(s)
on Schedule 13G
is hereby incorporated by reference.

Janus Capital has a direct 89.9% ownership stake in INTECH
Investment Management ("INTECH") and a direct 78.4% ownership
stake in Perkins Investment Management LLC("Perkins").  Due to the
above ownership structure, holdings for Janus Capital, Perkins
and INTECH are aggregated for purposes of this filing. Janus
Capital, Perkins and INTECH are registered investment advisers,
each furnishing investment advice to various investment companies
registered under Section 8 of the Investment Company Act of 1940
and to individual and institutional clients (collectively referred
to herein as "Managed Portfolios").

As a result of its role as investment adviser or sub-adviser to
the Managed Portfolios, Janus Capital may be deemed to be the
beneficial owner of 4,683,325
shares or 5.5% of the shares outstanding of Actions Sponsored ADR
held by such Managed Portfolios.  However, Janus Capital does not
have the right to receive any dividends from, or the proceeds from
the sale of, the securities held in the Managed Portfolios and
disclaims any ownership associated with such rights.
These shares were acquired in the ordinary course of business, and
not with the purpose of changing or influencing control of the
Issuer.
Item 10. Certification

By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the
ordinary course of business and were not acquired for the purpose
of and do not have the effect of changing
or influencing the control of the issuer of such securities and
were not acquired in connection with or as a participant in any
transaction having such purposes or effect.

SIGNATURES

After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement
is true, complete and correct.

JANUS CAPITAL MANAGEMENT LLC

By  /s/  David R. Kowalski                           2/17/2009
  David R. Kowalski,                              Date
    Senior Vice President and CCO

http://phx.corporate-ir.net/phoenix.zhtml?c=190317&p=irol-sec

http://news.xinhuanet.com/fortune/2009-02/13/content_10814883.htm

股市从来就不是理性的场所，涨的时候可能超出所有人的想象，本次行情涨幅又偏小的炬力目前股价距净资产有超过100%的空间。技术上处在蓄势状态，短线
有加速上行的要求。

炬力加速累积实力，珠海的研发总部竣工，上海的研发队伍也正以倍数成长上，一系列极具竞争力的新产品从2009年开始量产，2009年将是炬力分外忙碌
的一年。

http://www.18.com.cn/

http://news2.eastmoney.com/090203,1012380.html

Short Interest Share Information
Current   4.0K
Previous Month 46.6K

Genc experts pointed out ACTS seriously underestimated, shares could
be worth almost twice as investors overlook some of its valuable
assets,
Genc in its Sunday issued ;
According to a survey, the report pointed out ACTS could become an
acquisition target.
China is the world's largest car MP3 player manufacturing center,
world's production of 60 ~ 70%, the global rise in demand for car
audio products the impact of China's 2009 output is expected to grow
by more than 10%, ACTS has obvious advantages R & D and production,
has a mature supply chain, latest technology combined with the
function of new products, expand production capacity,
Actions Decoder technology functions has become more sophisticated,
Genc pointed out Chinese Government has launched a high-tech industry-
oriented incentives,  "China's chip design in a very strong, and
relatively favorable investment environment." "China in the OEM an
irreplaceable strength." China's IC design firms will be returned to
the track of rapid growth, expected growth rate than the past The
average growth rate is also higher than the 7 percentage points,
There is no doubt,

港股牛年有不錯的開始，牛年紅盤高開高收後，恒指連續兩天高收，成交增至441億元，午後更一度升236點，財政有309億元盈餘，財政狀況好過預期有
助回升市場氣氛，對下周一中國牛年紅盤有一定期望，以及憧憬中國將陸續有刺激經濟措施出台。